![]() ![]() What these status quo methodologies have in common is that they’re not safe and they’re not the standard of care. Meanwhile, more complex protocols that are dependent on manual calculations are prone to dangerous errors. Simplified protocols seek to ease provider burden but can’t provide personalized care. ![]() Insulin dosing in the inpatient setting has remained largely unchanged for half a century. Healthcare facilities can decide to implement one or more Glucommander treatment modules based on the units and care settings at their facilities: Glucommander is available in 3 different treatment modules that support patients and providers across the continuum of care. Glucommander provides insulin dosing decision support and is FDA-cleared for use with adult and pediatric patients ages 2 and above. Dashboards to support coordination of care.Dynamically adjusted timing for BG checks with automated reminders.Continuous surveillance of blood glucose levels across the entire patient population.In addition to dosing support, eGMS offers tools for doctors, nurses, pharmacists, CDCESs, hospital leadership and others to optimize glycemic management. ![]() ![]() The result? Patients experiencing glycemic management challenges get into target range faster, stay within tighter parameters and experience fewer insulin-related adverse drug events than patients treated with other protocols. Unlike paper protocols, sliding scale methods and digital insulin calculators, eGMS optimizes insulin therapy with Glucommander™, evidence-based, FDA-cleared software. Glucommander leverages real-time and historical data to personalize insulin dosing by learning each patient’s insulin sensitivity and anticipating future need. EGMS offers personalized insulin dosing decision support at the point of care. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |